» Articles » PMID: 24353433

Limiting and Controlling Carbapenem-resistant Klebsiella Pneumoniae

Overview
Publisher Dove Medical Press
Date 2013 Dec 20
PMID 24353433
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Carbapenem-resistant Klebsiella pneumoniae (CRKP) is resistant to almost all antimicrobial agents, is associated with substantial morbidity and mortality, and poses a serious threat to public health. The ongoing worldwide spread of this pathogen emphasizes the need for immediate intervention. This article reviews the global spread and risk factors for CRKP colonization/infection, and provides an overview of the strategy to combat CRKP dissemination.

Citing Articles

Fecal Carriage of Carbapenem Resistant and Associated Factors Among Admitted Patients in Saint Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia.

Mekonnen Y, Solomon S, Gebreyohanns A, Teklu D, Ayenew Z, Mihret A Infect Drug Resist. 2023; 16:6345-6355.

PMID: 37789843 PMC: 10542572. DOI: 10.2147/IDR.S418066.


Comparing the impact of two contact isolation modes for hospitalised patients with Clostridioides difficile infection on the quality of care.

Gehasi I, Livshiz-Riven I, Michael T, Borer A, Saidel-Odes L J Clin Nurs. 2022; 32(5-6):872-878.

PMID: 35761758 PMC: 10084440. DOI: 10.1111/jocn.16416.


Prevalence and antibiotic resistance of in a tertiary hospital in Hangzhou, China, 2006-2020.

Lin Z, Yu J, Liu S, Zhu M J Int Med Res. 2022; 50(2):3000605221079761.

PMID: 35216543 PMC: 8883314. DOI: 10.1177/03000605221079761.


Isolation, Genomic Analysis, and Preliminary Application of a Bovine Bacteriophage vB_Kpn_B01.

Luo Z, Geng S, Lu B, Han G, Wang Y, Luo Y Front Vet Sci. 2021; 8:622049.

PMID: 34540928 PMC: 8446446. DOI: 10.3389/fvets.2021.622049.


Emerging carbapenem-resistant sequence type 16 causing multiple outbreaks in a tertiary hospital in southern Vietnam.

Thi Nguyen T, Nguyen P, Le N, Nguyen L, Duong T, Ho N Microb Genom. 2021; 7(3).

PMID: 33565955 PMC: 8190610. DOI: 10.1099/mgen.0.000519.


References
1.
Borer A, Saidel-Odes L, Eskira S, Nativ R, Riesenberg K, Livshiz-Riven I . Risk factors for developing clinical infection with carbapenem-resistant Klebsiella pneumoniae in hospital patients initially only colonized with carbapenem-resistant K pneumoniae. Am J Infect Control. 2011; 40(5):421-5. DOI: 10.1016/j.ajic.2011.05.022. View

2.
Samra Z, Ofir O, Lishtzinsky Y, Madar-Shapiro L, Bishara J . Outbreak of carbapenem-resistant Klebsiella pneumoniae producing KPC-3 in a tertiary medical centre in Israel. Int J Antimicrob Agents. 2007; 30(6):525-9. DOI: 10.1016/j.ijantimicag.2007.07.024. View

3.
Naas T, Nordmann P, Vedel G, Poyart C . Plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC in a Klebsiella pneumoniae isolate from France. Antimicrob Agents Chemother. 2005; 49(10):4423-4. PMC: 1251528. DOI: 10.1128/AAC.49.10.4423-4424.2005. View

4.
Borer A, Saidel-Odes L, Riesenberg K, Eskira S, Peled N, Nativ R . Attributable mortality rate for carbapenem-resistant Klebsiella pneumoniae bacteremia. Infect Control Hosp Epidemiol. 2009; 30(10):972-6. DOI: 10.1086/605922. View

5.
Chen L, Anderson D, Paterson D . Overview of the epidemiology and the threat of Klebsiella pneumoniae carbapenemases (KPC) resistance. Infect Drug Resist. 2012; 5:133-41. PMC: 3460674. DOI: 10.2147/IDR.S26613. View